Autologous Bone Marrow Concentration for Rotator Cuff Tear
NCT ID: NCT03792594
Last Updated: 2020-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2017-05-12
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Platelet Rich Plasma Injection Combined With Exercise Rehabilitation in Patients With Rotator Cuff Tear
NCT03548662
Effect of the Muscle Strength and Range of Motion Training for Post-platelet Rich Plasma Injection in People With Rotator Cuff Partial Tear
NCT06192459
Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair
NCT05894265
The Effect of Amniotic Membrane Injection as An Addition to Physical Therapy in Patients With Rotator Cuff Tear
NCT05320419
A Pilot Cohort Study of Surgical and Non-surgical Management of Rotator Cuff Tears
NCT03021733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bone marrow concentration group
The patients receive arthroscopic repair with bone marrow concentration.
arthroscopic repair with bone marrow concentration
arthroscopic repair with bone marrow concentration
Historical control group
The patients receive arthroscopic repair only
arthroscopic repair
arthroscopic repair only
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
arthroscopic repair with bone marrow concentration
arthroscopic repair with bone marrow concentration
arthroscopic repair
arthroscopic repair only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 40 and 70 years
Exclusion Criteria
* With current or prior history of trauma or infection at shoulder
* With current diagnosis of coagulopathy
* With current or prior history of cancer
* With current or prior history of hematological disease
* Pregnancy
* Patients who will not cooperate with one-year followup
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aeon Biotechnology Corporation
INDUSTRY
Pei-Yuan Lee, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pei-Yuan Lee, MD
Superintendent
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pei-Yuan Lee, MD
Role: STUDY_CHAIR
Show Chwan Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Show Chwan Memorial Hospital
Changhua, Changhua, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Pei-Yuan Lee, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD106055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.